We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+6.27%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$69.4B
AUM Growth
-$5.97B
Cap. Flow
-$8.1B
Cap. Flow %
-11.68%
Top 10 Hldgs %
11.91%
Holding
4,468
New
542
Increased
1,601
Reduced
1,691
Closed
599

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$1.03B
2
UNH icon
UnitedHealth
UNH
+$686M
3
TSLA icon
Tesla
TSLA
+$387M
4
ABT icon
Abbott
ABT
+$380M
5
CVX icon
Chevron
CVX
+$328M

Sector Composition

Rank Sector Weight
1 Technology 20.26%
2 Healthcare 16.96%
3 Consumer Discretionary 12.82%
4 Consumer Staples 9.14%
5 Industrials 9.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STKH
3776
Steakholder Foods
STKH
$1.42M
$19K ﹤0.01%
18
-111
-86% -$103K
YJ
3777
Yunji
YJ
$6.16M
$19K ﹤0.01%
3,025
-1,930
-39% -$20.8K
ZCMD icon
3778
Zhongchao
ZCMD
$6.96M
$19K ﹤0.01%
2
MDVL
3779
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$19K ﹤0.01%
+1,590
New +$20.3K
TKAT
3780
DELISTED
Takung Art Co., Ltd.
TKAT
$19K ﹤0.01%
+54,100
New +$28K
EFSH
3781
DELISTED
1847 Holdings LLC
EFSH
$19K ﹤0.01%
+3
New +$32K
APGN
3782
DELISTED
Apexigen, Inc. Common Stock
APGN
$19K ﹤0.01%
44,150
+29,338
+198% +$13.9K
THER
3783
DELISTED
THERATECHNOLOGIES INC COM
THER
$19K ﹤0.01%
22,543
-22,657
-50% -$19.1K
DERM icon
3784
Journey Medical
DERM
$175M
$18K ﹤0.01%
+11,500
New +$18.5K
MLSS icon
3785
Milestone Scientific
MLSS
$35.3M
$18K ﹤0.01%
+21,197
New +$19.1K
ORIO
3786
Orion Digital Corp
ORIO
$15.4M
$18K ﹤0.01%
+8,900
New +$19K
NCTY
3787
The9 Ltd
NCTY
$68.1M
$18K ﹤0.01%
+2,389
New +$19.3K
FTK icon
3788
Flotek Industries
FTK
$852M
$17K ﹤0.01%
3,800
-9,458
-71% -$38.7K
GNLN icon
3789
Greenlane Holdings
GNLN
$1.22M
0
KRKR
3790
36Kr Holdings
KRKR
$5.68M
$17K ﹤0.01%
975
-1,290
-57% -$25.4K
KTTA icon
3791
Pasithea Therapeutics
KTTA
$15.4M
$17K ﹤0.01%
1,736
+186
+12% +$1.5K
PRFX icon
3792
PRF Technologies Ltd
PRFX
$3.04M
$17K ﹤0.01%
26
+4
+18% +$2.71K
VVOS icon
3793
Vivos Therapeutics
VVOS
$5.7M
$17K ﹤0.01%
1,342
-2,214
-62% -$21.7K
AWIN
3794
DELISTED
AERWINS Technologies Inc
AWIN
$17K ﹤0.01%
+403
New +$25.9K
CADL icon
3795
Candel Therapeutics
CADL
$733M
$16K ﹤0.01%
12,800
-8,200
-39% -$12.1K
LICN icon
3796
Lichen China
LICN
$18.1M
$16K ﹤0.01%
+59
New +$24.6K
NRXP icon
3797
NRX Pharmaceuticals
NRXP
$135M
$16K ﹤0.01%
3,350
+820
+32% +$4.93K
BNKK
3798
Bonk Inc
BNKK
$7.25M
$16K ﹤0.01%
1,106
-1,320
-54% -$18.7K
CHAI
3799
Core AI Holdings Inc
CHAI
$8.54M
$16K ﹤0.01%
+1
New +$56K
YYAI icon
3800
AiRWA Inc
YYAI
$126K
0

Similar funds

Renaissance Technologies's Q2 2023 Portfolio in Review

As of Q2 2023, Renaissance Technologies held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Renaissance Technologies withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Renaissance Technologies opened a new position in Berkshire Hathaway Class A worth $316M.

  • Renaissance Technologies's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
  • Renaissance Technologies added most to Apple in Q2 2023, an estimated $856M increase.
  • Renaissance Technologies's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
  • Renaissance Technologies fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
  • Renaissance Technologies's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
  • Renaissance Technologies opened 542 new positions and closed 599 in Q2 2023.
  • Renaissance Technologies's portfolio value fell 7.9% quarter-over-quarter to $69.4B.

Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.